Results 261 to 270 of about 1,142,872 (298)
Some of the next articles are maybe not open access.
Optimal induction and post-remission therapy for AML in first remission
Hematology, 2009Abstract Approximately 300,000 patients in the world are diagnosed annually with acute myeloid leukemia (AML). The median age at presentation has been steadily increasing over the past few decades and now is approaching 70 years. Although considerable progress has been made over the past 3 decades in the therapy of AML, two thirds of ...
openaire +2 more sources
Probiotics for induction of remission in ulcerative colitis
2006Ulcerative Colitis (UC) is an inflammatory condition affecting the colon with an incidence of approximately 10-20 per 100,000 per year. No existing intervention is effective in all patients with a proportion requiring colectomy. There are significant proportion of patients who experience adverse effects with current therapies.
P, Mallon +3 more
openaire +2 more sources
Budesonide for induction of remission in Crohn's disease
1996Corticosteroids continue to play a central role in induction of remission in active Crohn's disease. However, their use comes at a price of significant adverse effects when used repeatedly or for extended periods. Newer corticosteroid agents with limited systemic bioavailability offer a tantalizing option, if they can be shown to be efficacious and ...
A, Otley, A H, Steinhart
openaire +2 more sources
Budesonide for induction of remission in Crohn's disease
2008Corticosteroids play a key role in the induction of remission in Crohn's disease. However, corticosteroids can cause significant adverse events. Budesonide is an alternate enteral glucocorticoid with limited systemic bioavailability.The primary objective was to evaluate the efficacy and safety of oral budesonide for the induction of remission in Crohn ...
Cynthia H, Seow +4 more
openaire +2 more sources
Oral budesonide for induction of remission in ulcerative colitis
Cochrane Database of Systematic Reviews, 2015Corticosteroids are first-line therapy for induction of remission in ulcerative colitis. Although corticosteroids may improve symptoms, they have significant adverse effects. Steroids which act topically, with less systemic side-effects may be more desirable.
Mary E, Sherlock +4 more
openaire +2 more sources
Induction of remission in rheumatoid arthritis: criteria and opportunities
Rheumatology International, 2008The concept of remission in rheumatology is complicated by the lack of a single gold standard measurement, spontaneous remissions and the usage of several sets of remission criteria. Feasibility is reduced by traditional clinical practice, which does not include remission criteria monitoring.
VALESINI, Guido +3 more
openaire +3 more sources
Aminosalicylates for induction of remission or response in Crohn's disease
2010Controlled clinical trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in ...
Wee-Chian, Lim, Stephen, Hanauer
openaire +2 more sources
Vedolizumab for induction and maintenance of remission in ulcerative colitis
Cochrane Database of Systematic Reviews, 2014Cellular adhesion molecules play an important role in the pathogenesis of ulcerative colitis, making selective blockade of these molecules a promising therapeutic strategy. Vedolizumab, a recombinant humanized IgG1 monoclonal antibody, inhibits adhesion and migration of leukocytes into the gastrointestinal tract by binding the alpha4beta7 integrin ...
Stephen J, Bickston +6 more
openaire +2 more sources
Methotrexate for induction of remission in refractory Crohn's disease
2012Although corticosteroids are effective for induction of remission of Crohn's disease, many patients relapse when steroids are withdrawn or become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. The success of methotrexate as a treatment for rheumatoid arthritis led to its evaluation in patients with refractory Crohn'
John W D, McDonald +3 more
openaire +2 more sources
Methotrexate for induction of remission in refractory Crohn's disease
2002Although corticosteroids are effective for induction of remission of Crohn's disease, approximately 20% of patients who respond relapse when steroids are withdrawn and become steroid dependent (Binder 1985). Furthermore, corticosteroids exhibit significant adverse effects.
A A, Alfadhli +2 more
openaire +3 more sources

